On Friday, Shares of Celgene Corporation (NASDAQ:CELG), lost -0.50% to $117.38. The stock attained the volume of 5.05 million shares.
Celgene Corporation (CELG) will host a conference call and live audio webcast on Thursday, November 5, 2015 at 9 a.m. ET to talk about third quarter of 2015 financial and operational results. The third quarter will comprise the financial and operational results of Receptos Inc. following the August 27, 2015 close of the acquisition. The webcast can be accessed from the Investor Relations page at www.celgene.com.
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally.
At the end of Friday’s trade, Shares of Centurylink Inc (NYSE:CTL), declined -2.98% to $25.72.
It traded in a range of $25.61 and $26.58, exchanging hands with 5.02 million shares.
CenturyLink, Inc. (CTL) declared that it has extended its offer to exchange up to $500,000,000 aggregate principal amount of its 5.625% Senior Notes, Series X, due 2025, which have been registered under the Securities Act of 1933, as amended, for an equal principal amount of its outstanding unregistered 5.625% Senior Notes, Series X, due 2025.
The Exchange Offer, formerly planned to expire at 5:00 p.m., New York City time, on October 8, 2015, will now expire at 5:00 p.m., New York City time, on October 15, 2015, unless further extended by CenturyLink.
CenturyLink, Inc. provides various communications services to residential, business, governmental, and wholesale customers in the United States. It operates through two segments, Business and Consumer.
Finally, Shares of Alcatel Lucent SA (ADR) (NYSE:ALU), ended its last trade with -1.06% loss, and closed at $3.74.
Alcatel-Lucent (ALU) and BT are to commence an extensive consumer trial of the ultra-broadband access G.fast technology in Gosforth in the north-east of England.
G.fast – in which BT, Alcatel-Lucent and its Bell Labs research arm have played a pioneering development role - allows service providers to provide ultra-broadband Internet speeds in locations where deploying fiber-optic connectivity is difficult. It also eliminates the need to rewire entire buildings and homes, the most costly and time-consuming part of any fiber deployment. During the trial, G.fast will enable data speeds of up to 330 Mbps, delivered over copper infrastructure directly into premises.
Alcatel-Lucent’s G.fast technology has already been in trials with more than 30 operators worldwide. The BT trial will cover up to 2000 homes in Gosforth, near Newcastle-upon-Tyne, and will last for six to nine months. It follows a much smaller but very successful pilot conducted by BT and Alcatel-Lucent around Hethersett in Norfolk, earlier this year.
Alcatel-Lucent provides Internet protocol (IP) and cloud networking, and ultra- broadband access worldwide. The company’s Core Networking segment offers IP routing, carrier Ethernet, network functions virtualization, and software defined networking applications and infrastructure to meet the challenges of network traffic growth while supporting the delivery of cloud-enabled business, mobile, and residential services for service providers, mobile network operators, cable/multiple system operators, transportation, utilities, and large-scale enterprises.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
